# Rempex Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rempex-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: San Diego, US
- Website: www.rempexpharma.com
- Total disclosed funding: $76M
- Latest round: Series B (Nov 9, 2011)
- Investors on record: 5

## About

Founded in 2011, Rempex Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery and development of new antibacterial drugs to meet the growing clinical need created by multi-drug resistant bacterial pathogens.

## Funding rounds

- Series B, Nov 9, 2011, $68M — Adams Street Partners, Frazier Healthcare Partners, OrbiMed Advisors, SV Health Investors, Vivo Capital
- Series A, Jun 1, 2011, $8.5M — Adams Street Partners, OrbiMed Advisors, SV Health Investors

## Investors

- Adams Street Partners (https://capitalatlas.ai/funds/adams-street-partners) — Series A, Series B
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series A, Series B
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series A, Series B
- Frazier Healthcare Partners (https://capitalatlas.ai/funds/frazier-healthcare-partners) — Series B
- Vivo Capital (https://capitalatlas.ai/funds/vivo-capital) — Series B